A study highlights insufficient standardized safety and efficacy assessments for FDA-cleared AI/ML medical devices.
Key Details
- 1Cross-sectional analysis of FDA-cleared AI/ML-enabled devices was conducted.
- 2The study found lack of standardized efficacy and safety reporting in device clearance.
- 3Suggested need for dedicated regulatory pathways and post-market AI/ML safety surveillance.
- 4Study was published in JAMA Health Forum and led by Dr. Ravi B. Parikh.
Why It Matters
As imaging AI tools increasingly enter clinical use, robust regulatory oversight is critical for patient safety and clinician trust. Gaps in FDA reporting and surveillance could impact the safe integration of AI in radiology practice.
Source
EurekAlert
Related News
•EurekAlert
AI Deep Learning Model Enhances Echocardiogram RV Assessment and Prognosis
Researchers developed DROID-RV, a deep learning tool that automates right ventricular assessment from echocardiograms, showing strong prognostic links with cardiovascular outcomes.
•EurekAlert
Penn Medicine's Percival AI Detects Hidden Health Risks in CT Scans
Penn Medicine's Percival AI leverages CT scans to uncover unseen health risks and disease patterns, expanding the utility of radiological imaging.
•EurekAlert
SNU Team Develops Omnimodal AI Model for Robotic Task Control, Eyes Medical Use
SNU engineers unveiled a unified AI model, Dynin-Robotics, that interprets language, predicts outcomes, and executes real-world robotic tasks with potential for medical applications.